Alcon acquires rights to three Sirion products.
- Published in:
- Optometry Times, 2010, v. 2, n. 2, p. 3
- By:
- Publication type:
- Article
Works matching DE "SIRION Therapeutics Inc."
Results: 11
1
2
Alcon plans to purchase rights to two ophthalmic agents from Sirion; committee rejects Novartis' merger proposal.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 4, p. 33
- Publication type:
- Article
3
Industry Pipeline.
- Published in:
- Ocular Surgery News, 2009, v. 27, n. 20, p. 98
- Publication type:
- Article
4
Industry Pipeline.
- Published in:
- Ocular Surgery News, 2009, v. 27, n. 18, p. 52
- Publication type:
- Article
5
Topical steroid targets postop inflammation and pain.
- Published in:
- Ocular Surgery News, 2008, v. 26, n. 19, p. 30
- By:
- Publication type:
- Article
6
Industry News in Brief.
- Published in:
- Ocular Surgery News, 2008, v. 26, n. 7, p. 12
- By:
- Publication type:
- Article
7
Durezol™ receives US FDA approval for the treatment of postoperative ocular pain and inflammation.
- Published in:
- Expert Review of Ophthalmology, 2008, v. 3, n. 4, p. 361
- Publication type:
- Article
8
US FDA priority review for postoperative ocular inflammation drug.
- Published in:
- 2008
- Publication type:
- Product Review
9
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 21, p. 1890
- Publication type:
- Article
10
New topical corticosteroid treats postoperative ocular pain.
- Published in:
- American Journal of Health-System Pharmacy, 2008, v. 65, n. 15, p. 1394, doi. 10.2146/news080060
- By:
- Publication type:
- Article
11
INDUSTRY NEWS.
- Published in:
- Optometric Education, 2010, v. 35, n. 2, p. 47
- Publication type:
- Article